AACC advises against lab testing for premature birth

By Will Morton, LabPulse.com contributing writer

June 3, 2021 -- Clinical lab tests that try to predict preterm birth shouldn't be used routinely due to a lack of evidence that the tests improve the outcomes of pregnant women or babies, according to a new statement by the American Association for Clinical Chemistry (AACC).

Preterm delivery is an ongoing problem that can lead to numerous complications for both infants who survive birth and their mothers, according to AACC. To address the issue, medical providers have turned to clinical lab tests that measure fetal fibronectin (fFN), interleukin 6, and placental alpha microglobulin-1 (PAMG-1) that may predict whether a woman will deliver preterm.

But these tests have low positive predictive values, which means that many women who are identified by the tests as being likely to deliver prematurely will not actually give birth early, according to the AACC.

The group said there was one exception to its guidance: patients who present with symptoms of premature labor and who are at high risk of preterm delivery due to cervical length. In these individuals, a positive PAMG-1 result may help to identify women who are likely to deliver within seven days.

The AACC suggests that laboratory professionals and obstetric-gynecology specialists discuss all available recommendations on preterm birth testing together and take a collaborative approach to developing institutional testing strategies for preterm birth that best meet the needs of their patients.

The full guidance document is available on the AACC site.

AACC releases guidance on kidney injury lab testing
The American Association for Clinical Chemistry (AACC) released guidance on lab testing for acute kidney injury patients that proposes new diagnostic...
AACC moves annual meeting from Anaheim to Atlanta
The American Association for Clinical Chemistry (AACC) is moving the location of its annual meeting from Anaheim, CA, to Atlanta and is shifting the date...
AACC sells Lab Tests Online to OneCare Media
The American Association for Clinical Chemistry (AACC) has sold its Lab Tests Online website to digital health company OneCare Media. Lab Tests Online...
Sera validates blood test in pregnant women at risk of bad outcomes
Sera Prognostics has reported data validating its blood biomarker test that can help identify mothers and infants at risk for severe adverse pregnancy...
NIH study finds vaginal bacteria could predict preterm births
A research study funded by the U.S. National Institutes of Health (NIH) indicates that differences in vaginal bacteria could predict the risk of preterm...

Copyright © 2021 LabPulse.com

Last Updated ls 6/3/2021 3:12:10 PM